DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

CIDCO Auditorium & Convention Centre

2026年9月11日 (金) 午前 8:00 - 2026年9月12日 (土) 午前 9:00

201, Sector 30, Vashi, Navi Mumbai 400703, MH, India

DIA India Annual Meeting - 2026

Where India Meets the World in Healthcare Innovation

概要

The DIA India Annual Meeting (IAM) 2026 marks a defining moment for India’s life sciences and healthcare ecosystem. As science, technology, and regulation converge at unprecedented speed, IAM 2026 emerges as the platform where future-ready strategies are shaped, tested, and translated into real-world impact.

Bringing together global and Indian leaders from pharma, biotech, medical devices, regulators, academia, and technology, IAM 2026 goes beyond dialogue-it enables decision-making, collaboration, and action across the full product lifecycle.

With six deep-dive tracks and two high-impact plenary sessions, this year’s meeting reflects the expanding scope and complexity of modern healthcare, from advanced therapies and digital innovation to regulatory transformation, patient safety, and evidence generation. IAM 2026 is designed for leaders who are not just adapting to change, but shaping what comes next.

Plenary Sessions (Flagship Conversations)

1. Plenary I: The Future of Healthcare Innovation

A global perspective on science, regulation, and patient-centric transformation
Senior leaders and regulators share their vision on how innovation, policy, and trust will define healthcare delivery in the next decade.

2. Plenary II: From Promise to Practice

Translating science into scalable, sustainable healthcare solutions
A cross-sector dialogue on execution-what it takes to move breakthrough ideas from labs to lives, at speed and with integrity.

Conference Tracks – 2026

1. Advanced Therapy Medicinal Products (ATMPs)

Cell & gene therapies, RNA-based medicines, personalized treatments, and platform technologies, exploring development, regulation, manufacturing, and access pathways for next-generation therapies.

2. Clinical Development

Advancing clinical and medical science and high-quality trial execution to deliver patient-centric evidence across the clinical development continuum, with India’s growing role in global clinical development.

3. Pharmacovigilance & Patient Safety

Next-generation safety systems, AI-enabled signal detection, risk management across products, and evolving global PV expectations.

4. Regulatory Science & Policy
Regulatory convergence, reliance pathways, digital submissions, evolving Indian and global frameworks, and science-driven decision-making.

5. Medical Affairs & Evidence Generation

Strategic medical leadership, real-world evidence, scientific engagement, and the expanding role of Medical Affairs in value creation.

6. Data Science, RWE & Artificial Intelligence

AI, advanced analytics, real-world data, interoperability, and governance—turning data into insight, trust, and better outcomes.

Why IAM 2026 Matters

IAM 2026 is not just a conference; it is a strategic convergence point for those committed to advancing healthcare in India and globally.
If you are looking to anticipate change, influence policy, adopt innovation responsibly, and deliver better outcomes for patients, this is where the conversation and the future begin.

参加対象

IAM 2026 is designed for professionals shaping healthcare across strategy, science, and execution:

• Pharma, Biotech & MedTech Leaders
R&D, Clinical Development, Regulatory Affairs, Quality, Safety, Medical Affairs, Market Access

• Regulatory Authorities & Policy Leaders
India and global agencies, regulatory strategists, compliance leaders

• Clinical & Research Professionals
Investigators, trial managers, biostatisticians, medical writers

• Technology & Data Leaders
AI, digital health, analytics, RWE, IT and platform providers

• CROs & Solution Providers
Clinical, regulatory, PV, data, and digital services

• Academia & Research Institutions

• Students & Young Professionals
The next generation of life sciences leaders

• Industry Associations & Policy Influencers

学習目的

Participants at DIA IAM 2026 will:

• Gain forward-looking insights into emerging therapies, technologies, and regulatory models
• Understand how to design agile, patient-centric development strategies in a rapidly evolving environment
• Explore practical approaches to AI, real-world evidence, and digital transformation
• Engage directly with regulators and industry leaders to align on expectations and best practices
• Build cross-functional and cross-sector collaborations that accelerate innovation
• Take home actionable frameworks to improve decision-making, compliance, and impact

プログラム委員会

  • Gaurav  Mathur, PHD
    Gaurav Mathur, PHD Senior Director, Regulatory Affairs
    Parexel International, Bengaluru, India
  • Sanish  Davis
    Sanish Davis R&D Director, GCO India
    Johnson & Johnson Innovative Medicine, India
  • Subrat  Ray
    Subrat Ray Regional Director Medical Affairs – Women’s Health (APJ and EEMEA)
    Organon (India) Pvt Ltd, India
  • Chitra  Lele, PHD
    Chitra Lele, PHD Managing Director, Life Sciences Consulting
    NTT DATA, India
  • Vivek  Ahuja, MD
    Vivek Ahuja, MD Program Chair, Executive Vice President, Pharmacovigilance
    EVERSANA, India
  • Praveen  Raj
    Praveen Raj Medical Affairs Leader & Health Economics Expert
    Biocon, India
  • Sridevi  Nagarajan, PHD
    Sridevi Nagarajan, PHD DIA Communities Chair for AI in Healthcare
    Ayusarogya, United Kingdom
  • Ashok Kumar  Swain, MD
    Ashok Kumar Swain, MD General Manager & Executive Director
    DIA, India

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。